Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for July 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 27 to 31, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
U.S. Puts Up Another $2.1 Billion for Potential COVID-19 Vaccine
FRIDAY, July 31, 2020 (HealthDay News) — The United States is buying up another potential COVID-19 vaccine, the Associated Press reported Friday.
AP News Article
Plenty of COVID-19 Vaccine Coming, Fauci Says
FRIDAY, July 31, 2020 (HealthDay News) — When a COVID-19 vaccine is approved, there should be plenty of it available, Anthony Fauci, M.D., infectious diseases chief at the U.S. National Institutes of Health, told a House panel Friday, the Associated Press reported.
AP News Article
Johns Hopkins University
Bacterial, Fungal Coinfection Uncommon in COVID-19 Patients
FRIDAY, July 31, 2020 (HealthDay News) — Bacterial and fungal infections are uncommon in hospitalized COVID-19 patients, but coinfection is associated with high mortality and antibiotic use is widespread, according to a study published in the July issue of Infection Control & Hospital Epidemiology.
FDA Warns Companies Illegally Selling Hangover Cures
THURSDAY, July 30, 2020 (HealthDay News) — The U.S. Food and Drug Administration has sent warning letters to seven companies for illegally selling products they claim will cure, treat, mitigate, or prevent hangovers.
Cinnamon Supplementation May Improve Blood Glucose Control
THURSDAY, July 30, 2020 (HealthDay News) — In individuals with prediabetes, 12 weeks of cinnamon supplementation improved fasting plasma glucose (FPG) and glucose tolerance, according to a study published online July 21 in the Journal of the Endocrine Society.
Remdesivir Shortages Plague Some Hospitals, Pharmacists Say
THURSDAY, July 30, 2020 (HealthDay News) — One-third of pharmacists say they do not have enough remdesivir to treat all COVID-19 patients who are eligible for it, according to the results of a survey released by the American Society of Health-System Pharmacists (ASHP).
Most Gynecologic Cancer Therapy Not Tied to Higher COVID-19 Risk
THURSDAY, July 30, 2020 (HealthDay News) — For gynecologic oncology patients with COVID-19, the case fatality rate is 14.0 percent, and chemotherapy and recent major surgery do not predict COVID-19 severity or mortality, according to a study published online July 30 in Cancer.
Nirsevimab Injection Cuts RSV-Linked Infections in Preemies
THURSDAY, July 30, 2020 (HealthDay News) — Nirsevimab prevents respiratory syncytial virus (RSV)-associated lower respiratory tract infections in healthy preterm infants, while maternal RSV fusion (F) protein nanoparticle vaccination did not meet the prespecified criterion for efficacy, according to two studies published in the July 30 issue of the New England Journal of Medicine.
Abstract/Full Text – Griffin
Abstract/Full Text – Madhi
Editorial (subscription or payment may be required)
Teen HPV Vaccination Rates Suboptimal
THURSDAY, July 30, 2020 (HealthDay News) — Lack of parental intent to initiate and complete the human papillomavirus (HPV) vaccine series for adolescents is a major public health concern, according to a study published online July 21 in The Lancet Public Health.
Delayed Treatment of Upper Respiratory Tract Infections Tied to Hospitalization Risk
THURSDAY, July 30, 2020 (HealthDay News) — Delayed treatment of upper respiratory tract infections (URTI) with antibiotics is associated with an increased risk for hospital admissions, according to a study published online June 29 in Clinical Infectious Diseases.
Low Health Literacy Tied to Worse Heart Failure Outcomes
WEDNESDAY, July 29, 2020 (HealthDay News) — Poor health literacy is associated with worse heart failure outcomes, according to a review published in the June issue of JACC: Heart Failure.
SGLT-2 Inhibitors May Raise Risk for Diabetic Ketoacidosis
WEDNESDAY, July 29, 2020 (HealthDay News) — In patients with type 2 diabetes, sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with an increased risk for diabetic ketoacidosis (DKA), according to a study published online July 28 in the Annals of Internal Medicine.
Cost-Sharing Caps for Insulin Would Benefit Youth With T1D
WEDNESDAY, July 29, 2020 (HealthDay News) — For privately insured young children and adults with type 1 diabetes, the mean annual out-of-pocket spending on insulin was $494 in 2018, and many would benefit from price caps, according to a research letter published online July 27 in JAMA Pediatrics.
Relapses Linked to Accelerated Disability Progression in SPMS
TUESDAY, July 28, 2020 (HealthDay News) — For patients with secondary progressive multiple sclerosis (SPMS), relapses are associated with accelerated disability progression, according to a study published online July 27 in JAMA Neurology.
Increase Found in Suicide-Related Exposure Rates to OTC Analgesics
TUESDAY, July 28, 2020 (HealthDay News) — There has been a recent increase in suicide-related exposure rates to over-the-counter (OTC) analgesics, according to a study published online July 26 in Pharmacoepidemiology & Drug Safety.
FDA Warns Again About Dangers of Methanol-Based Hand Sanitizers
TUESDAY, July 28, 2020 (HealthDay News) — The U.S. Food and Drug Administration is warning consumers not to use alcohol-based hand sanitizers containing methanol, or wood alcohol, which is used in fuel and antifreeze and is toxic if absorbed through the skin or life-threatening if ingested.
Vertebral Fractures Up With Long-Term Delay of Denosumab
TUESDAY, July 28, 2020 (HealthDay News) — Compared with on-time dosing, delay of denosumab by more than 16 weeks is associated with an increased risk for vertebral fractures, according to a study published online July 28 in the Annals of Internal Medicine.
Postmarketing Surveillance Helps Identify Vaccine Safety Issues
TUESDAY, July 28, 2020 (HealthDay News) — A review of all safety-related labeling changes for FDA-approved vaccines during a 20-year period shows vaccines are largely safe, and many of the safety issues are identified through postmarketing surveillance, according to a study published online July 28 in the Annals of Internal Medicine.
NSAID Use Linked to Cardiovascular, Bleeding Events Post-MI
MONDAY, July 27, 2020 (HealthDay News) — For patients with myocardial infarction (MI), nonsteroidal anti-inflammatory drug (NSAID) treatment is associated with a significantly increased risk for cardiovascular and bleeding events, according to a study published in the Aug. 4 issue of the Journal of the American College of Cardiology.
COVID-19 Vaccine Candidate Now in Final Phase Testing
MONDAY, July 27, 2020 (HealthDay News) — A vaccine developed by the U.S. National Institutes of Health and Moderna has entered the final phase of testing, the Associated Press reported Monday.
AP News Article
Large Proportion of COVID-19 Studies Have Low-Level Evidence
MONDAY, July 27, 2020 (HealthDay News) — A large proportion of studies on COVID-19 have a low level of evidence, according to a research letter published online July 27 in JAMA Internal Medicine.
Impact on Glucocorticoids in COVID-19 Varies With CRP Levels
MONDAY, July 27, 2020 (HealthDay News) — The impact of glucocorticoid treatment on patients with COVID-19 varies according to C-reactive protein (CRP) levels, according to a study published online July 22 in the Journal of Hospital Medicine.
Spine Surgery Patients Prescribed the Most Postoperative Narcotics
MONDAY, July 27, 2020 (HealthDay News) — Spine surgery patients are prescribed the most narcotics in the three months following surgery, and patient-reported pain at hospital discharge is associated with increased narcotic use in this period, according to a study published in the July 1 issue of the Journal of the American Academy of Orthopaedic Surgeons.
FDA: Doctors Should Discuss Opioid OD Antidote With Patients
FRIDAY, July 24, 2020 (HealthDay News) — Doctors should tell patients and caregivers about the overdose antidote naloxone when they prescribe opioid painkillers such as Percocet and OxyContin and medicines to treat opioid addiction, including buprenorphine, methadone, and naltrexone, the U.S. Food and Drug Administration said Thursday.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 20 to 24, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
CDC Guidance Issued for Testing, Management of HCP Exposed to Hep C
FRIDAY, July 24, 2020 (HealthDay News) — In a U.S. Centers for Disease Control and Prevention guidance report, published in the July 24 issue of Morbidity and Mortality Weekly Report, recommendations are presented for testing and clinical management of health care personnel (HCP) exposed to the hepatitis C virus (HCV).
Chimpanzee Adenovirus-Vectored Vaccine Promising for COVID-19
FRIDAY, July 24, 2020 (HealthDay News) — A chimpanzee adenovirus-vectored vaccine (ChAdOx1 nCoV-19) expressing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein has acceptable safety and induces antibody and T-cell immune responses, according to a study published online July 20 in The Lancet.
Financial Health of Hospitals ‘Dire’ Due to COVID-19
THURSDAY, July 23, 2020 (HealthDay News) — COVID-19 continues to cause financial peril for U.S. hospitals, according to a report released by the American Hospital Association (AHA).
Ad5-Vectored COVID-19 Vaccine Immunogenic in Healthy Adults
THURSDAY, July 23, 2020 (HealthDay News) — The nonreplicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine appears safe and induces immune responses at a dose of 5×1010 viral particles, according to a study published online July 20 in The Lancet.
Role of COVID-19 Treatments Explored in Patients With Cancer
THURSDAY, July 23, 2020 (HealthDay News) — For adults with invasive cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, treatment with hydroxychloroquine in combination with any other drug is associated with increased mortality, according to a study published online July 22 in Cancer Discovery.
Varenicline Strongly Recommended for Smoking Cessation
THURSDAY, July 23, 2020 (HealthDay News) — Varenicline is strongly recommended over the patch for adult smokers hoping to quit, according to an American Thoracic Society practice guideline published online in the July 15 issue of the American Journal of Respiratory and Critical Care Medicine.
U.S. Reaches Deal for Nearly 600 Million Doses of COVID-19 Vaccine
WEDNESDAY, July 22, 2020 (HealthDay News) — A nearly $2 billion contract with pharmaceutical company Pfizer and a German biotechnology firm will provide the United States with up to 600 million doses of a COVID-19 vaccine being developed by the companies, the U.S. government says.
The New York Times Article
Pembrolizumab Use Supported in Advanced Melanoma
WEDNESDAY, July 22, 2020 (HealthDay News) — Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of a BRAF inhibitor (BRAFi) with or without MEK inhibitor (MEKi) therapy, according to a study published online July 20 in JAMA Oncology.
Some With Opioid Use Disorder Rejected From Post-Acute Care
WEDNESDAY, July 22, 2020 (HealthDay News) — Individuals hospitalized with opioid use disorder (OUD) frequently experience explicit discrimination when being rejected from post-acute care, according to a study published online July 15 in the Journal of Addiction Medicine.
Parents Make Some Common Sunscreen Mistakes
TUESDAY, July 21, 2020 (HealthDay News) — Some parents may not be adequately protecting their children from the sun, according to a new C.S. Mott Children’s Hospital national poll from the University of Michigan in Ann Arbor.
U.K. Study Looks at Stepping Down Meds in Stable Asthma
TUESDAY, July 21, 2020 (HealthDay News) — Asthma patients are increasingly prescribed higher levels of treatment, and few patients step down medications, according to a study published online July 21 in PLOS Medicine.
Recommendations Updated for Barrier Method Use Among Teens
TUESDAY, July 21, 2020 (HealthDay News) — In an American Academy of Pediatrics policy statement, published online July 20 in Pediatrics, updated recommendations are presented relating to use of barrier methods for adolescents engaging in sexual activity.
Policy Statement
Technical Report
Clinical Report
Prenatal Cannabis Exposure Tied to Childhood Sleep Problems
TUESDAY, July 21, 2020 (HealthDay News) — Prenatal cannabis exposure is associated with child sleep outcomes, according to a study published online June 28 in Sleep Health.
Reduced-Dose Prasugrel Efficacious for Acute Coronary Syndrome
MONDAY, July 20, 2020 (HealthDay News) — For elderly or low-weight patients with acute coronary syndrome (ACS), a reduced dose of prasugrel is efficacious compared with ticagrelor, according to a study published online July 21 in the Annals of Internal Medicine.
28-Day Mortality in COVID-19 Lower With Dexamethasone
MONDAY, July 20, 2020 (HealthDay News) — Dexamethasone lowers 28-day mortality in patients hospitalized with COVID-19 who are receiving invasive mechanical ventilation or oxygenation alone, according to a study published online July 17 in the New England Journal of Medicine.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 13 to 17, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Call for ‘Challenge Trials’ to Hasten COVID-19 Vaccine Development
FRIDAY, July 17, 2020 (HealthDay News) — The U.S. government should make immediate preparations for clinical trials in which volunteers are exposed to the new coronavirus to speed development of a vaccine, more than 100 top scientists say in a letter to the U.S. National Institutes of Health.
CNN Article
Lopinavir/Ritonavir COVID-19 Treatment Linked to Bradycardia
FRIDAY, July 17, 2020 (HealthDay News) — Lopinavir/ritonavir (LPV/RTV) treatment of COVID-19 is associated with an increased risk for bradycardia, according to a study published online July 9 in Circulation: Arrhythmia and Electrophysiology.
Flu Vaccine Cuts Cardiovascular Mortality in Adults With Diabetes
FRIDAY, July 17, 2020 (HealthDay News) — Influenza vaccination may improve outcomes in patients with diabetes, according to a study published online July 9 in Diabetes Care.
U.S. Must Spend $75 Billion to Improve COVID-19 Testing, Report Says
THURSDAY, July 16, 2020 (HealthDay News) — The United States faces “an impending disaster” from the coronavirus pandemic and should spend $75 billion to improve its diagnostic testing system for COVID-19, a Rockefeller Foundation report says.
SARS-CoV-2 mRNA-1273 Induces Immune Response
THURSDAY, July 16, 2020 (HealthDay News) — The candidate vaccine mRNA-1273, which encodes the stabilized prefusion severe acute respiratory syndrome coronavirus 2 spike protein, induces immune responses in healthy participants, according to a phase 1 study published online July 14 in the New England Journal of Medicine.
Physical Distancing Interventions Cut Incidence of COVID-19
THURSDAY, July 16, 2020 (HealthDay News) — Physical distancing interventions are associated with a reduced incidence of COVID-19 globally, according to a study published online July 15 in The BMJ.
Impact of COVID-19 Estimated on HIV, TB, Malaria Services
THURSDAY, July 16, 2020 (HealthDay News) — Disruption to services for HIV, tuberculosis, and malaria due to COVID-19 could lead to considerable loss of life in low- and middle-income countries, according to a study published online July 13 in The Lancet Global Health.
Ticagrelor-Aspirin Beneficial for Mild-to-Moderate Stroke, TIA
THURSDAY, July 16, 2020 (HealthDay News) — Ticagrelor-aspirin is associated with a reduced risk for the composite of stroke or death within 30 days of mild-to-moderate acute noncardioembolic ischemic stroke or transient ischemic attack (TIA), according to a study published in the July 16 issue of the New England Journal of Medicine.
COVID-19 Vaccine Initiative May Favor Rich Countries
WEDNESDAY, July 15, 2020 (HealthDay News) — A global COVID-19 vaccine initiative has been formed with the objective of ensuring fair distribution of vaccines worldwide, but it may benefit rich countries more than poor nations.
AP News Article
Childhood Vaccinations Decline During COVID-19 Pandemic
WEDNESDAY, July 15, 2020 (HealthDay News) — There has been a decrease in childhood vaccinations during the COVID-19 pandemic, the United Nations says.
Roflumilast Cream Promising for Chronic Plaque Psoriasis
WEDNESDAY, July 15, 2020 (HealthDay News) — Roflumilast cream is superior to placebo vehicle cream for reducing psoriasis severity, according to a study published in the July 16 issue of the New England Journal of Medicine.
HCQ During Pregnancy May Prevent Congenital Heart Block
WEDNESDAY, July 15, 2020 (HealthDay News) — For anti-SSA/Ro-positive mothers with a previous pregnancy complicated by congenital heart block (CHB), hydroxychloroquine may reduce the recurrence of CHB, according to a study published in the July 21 issue of the Journal of the American College of Cardiology.
Medication Use Linked to Weight Gain in Postmenopausal Women
WEDNESDAY, July 15, 2020 (HealthDay News) — For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years, according to a study published online July 15 in Menopause.
Global Population Anticipated to Peak in 2064
WEDNESDAY, July 15, 2020 (HealthDay News) — The global population is anticipated to peak in 2064 and then decline to year 2100, according to a study published online July 14 in The Lancet.
Survival Up With Tocilizumab in Ventilated COVID-19 Patients
WEDNESDAY, July 15, 2020 (HealthDay News) — For patients with COVID-19 requiring mechanical ventilation, tocilizumab is associated with improved survival, according to a study published online July 11 in Clinical Infectious Diseases.
Squirrel With Bubonic Plague Found in Colorado Town
TUESDAY, July 14, 2020 (HealthDay News) — After a squirrel tested positive for the bubonic plague in the town of Morrison in Colorado, health officials are warning that the disease can be contracted by household pets and people.
Layoffs Cost 5.4 Million Americans Their Health Insurance
TUESDAY, July 14, 2020 (HealthDay News) — About 5.4 million Americans lost their health insurance after being laid off between February and May due to the COVID-19 pandemic, a new study shows.
The New York Times Article
Genomic Alterations Distinct for Black Men With Prostate Cancer
TUESDAY, July 14, 2020 (HealthDay News) — African-American (AFR) men with prostate cancer have distinct genomic alterations from European-American (EUR) men, according to a study published online July 10 in Clinical Cancer Research.
Some Hospitals in COVID-19 Hotspots Running Short of Remdesivir
MONDAY, July 13, 2020 (HealthDay News) — Some U.S. hospitals in COVID-19 hotspots are running short of the antiviral drug remdesivir — the only drug authorized by the U.S. Food and Drug Administration to treat the disease — while hospitals in other regions have stocks of the drug that are going unused.
CNN Article
Policy Guides Medical Marijuana Use at Pediatric Hospital
MONDAY, July 13, 2020 (HealthDay News) — Development of institutional policy and clinical support services is beneficial for pediatric hospitals interested in use of medical marijuana (MMJ), according to a special article published online July 13 in Pediatrics.
Arthritis Patients Needing to Shelter in Place Require More Support
MONDAY, July 13, 2020 (HealthDay News) — The Norfolk Arthritis Register has released an interim report on the impact of COVID-19 restrictions on people living with inflammatory arthritis who were advised to shelter at home due to increased vulnerability to COVID-19 because of medications.
Risk for Heart Failure Increased for Women Taking β-Blockers
MONDAY, July 13, 2020 (HealthDay News) — Women taking β-blockers for hypertension have an increased risk for developing heart failure when they present to the hospital with acute coronary syndrome, according to a study published online July 10 in Hypertension.
Adherence to Prophylaxis for EGFRi-Linked Rash Beneficial
MONDAY, July 13, 2020 (HealthDay News) — Increasing adherence to evidence-based prophylaxis protocols for epidermal growth factor receptor inhibitor (EGFRi)-associated rash can reduce interventions and toxicity-associated chemotherapy interruptions, according to a study published online July 1 in JAMA Dermatology.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of July 6 to 10, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
FRIDAY, July 10, 2020 (HealthDay News) — There is more good news on the effectiveness of the antiviral drug remdesivir against COVID-19, according to new clinical trial results from the drug’s maker.
Risk for COVID-19 Increased for Adults Taking PPIs
FRIDAY, July 10, 2020 (HealthDay News) — Adults taking proton pump inhibitors (PPIs) have an increased risk for having a positive COVID-19 test, with evidence of a dose-response relationship, according to a study published online July 7 in preprint format in the American Journal of Gastroenterology.
Electronic Health Records Fail to Detect Many Medication Errors
THURSDAY, July 9, 2020 (HealthDay News) — There is wide variation in the safety performance of electronic health record (EHR) systems used in U.S. hospitals, according to a study recently published in JAMA Network Open.
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
THURSDAY, July 9, 2020 (HealthDay News) — For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of Medicine.
2008 to 2018 Saw Increase in Shingles Vaccination in Over 60s
THURSDAY, July 9, 2020 (HealthDay News) — From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years and older, with demographic, socioeconomic, and geographic variations in vaccination rates, according to a July data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Employers Can Refuse to Provide Birth Control Coverage: U.S Supreme Court
WEDNESDAY, July 8, 2020 (HealthDay News) — More than 70,000 U.S. women could be left without cost-free birth control after the Supreme Court upheld a Trump administration policy change that permits some employers to refuse to provide contraceptive coverage on religious or moral grounds.
AP News Article
Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis
WEDNESDAY, July 8, 2020 (HealthDay News) — Upadacitinib monotherapy results in improved outcomes versus methotrexate for patients with predominantly early rheumatoid arthritis, according to a study published online July 8 in Arthritis & Rheumatology.
February to March 2020 Saw Surge in Hydroxychloroquine Rx
WEDNESDAY, July 8, 2020 (HealthDay News) — From February to March 2020, there was a considerable increase in the number of patients receiving outpatient prescriptions for hydroxychloroquine, chloroquine, and azithromycin, according to a research letter published online July 6 in JAMA Internal Medicine.
American Cancer Society Updates HPV Vaccination Guidelines
WEDNESDAY, July 8, 2020 (HealthDay News) — The American Cancer Society has updated guidelines on human papillomavirus (HPV) vaccination, emphasizing that vaccination should be routinely offered at age 9 to 12 years; the updated recommendations were published online July 8 in CA: A Cancer Journal for Clinicians.
Statin Use May Cut All-Cause, CVD Mortality in Those 75 and Older
WEDNESDAY, July 8, 2020 (HealthDay News) — In U.S. veterans aged 75 years and older, statin use is associated with reduced all-cause and cardiovascular mortality, according to a study published in the July 7 issue of the Journal of the American Medical Association.
Long-Acting Drug Targeting Capsid Protein Promising for HIV
WEDNESDAY, July 8, 2020 (HealthDay News) — A small molecule that disrupts the functions of the HIV capsid protein, GS-6207, demonstrates a reduction in plasma viral load and shows sustained plasma exposure, according to a study published online July 1 in Nature.
Company Gets $1.6 Billion From U.S. Government for COVID-19 Vaccine
TUESDAY, July 7, 2020 (HealthDay News) — Vaccine maker Novavax will receive $1.6 billion from the U.S. government to provide 100 million doses of a COVID-19 vaccine by early 2021, the Maryland-based company said Monday.
The New York Times Article
COVID-19 Antibody Cocktail Begins Late-Stage Human Trials
TUESDAY, July 7, 2020 (HealthDay News) — Late-stage human trials to assess whether a double antibody cocktail can prevent and treat COVID-19 infection have started, biotechnology company Regeneron said Monday.
CNN Article
Efforts to Reduce New HIV Infections in Children Faltering
TUESDAY, July 7, 2020 (HealthDay News) — Efforts to reduce new HIV infections in children worldwide are faltering, according to a new report on progress toward Start Free, Stay Free, AIDS Free targets.
Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
TUESDAY, July 7, 2020 (HealthDay News) — Prescriptions for oral steroid bursts are associated with a 1.8- to 2.4-fold increased risk for severe adverse events within the first month after initiation of drug therapy, according to a study published online July 7 in the Annals of Internal Medicine.
Review: Pre/Probiotics May Be Useful for Depression, Anxiety
TUESDAY, July 7, 2020 (HealthDay News) — Pre/probiotic therapy may be useful for patients with depression and/or anxiety disorders, according to a review published online July 6 in BMJ Nutrition, Prevention & Health.
Complementary, Alternative Medicine Use Increasing for MS
TUESDAY, July 7, 2020 (HealthDay News) — For people with multiple sclerosis (pwMS), there has been an increase in use of complementary and alternative medicine (CAM), according to a study published in the June issue of Multiple Sclerosis and Related Disorders.
FDA Warns About Hand Sanitizers With Methanol
MONDAY, July 6, 2020 (HealthDay News) — A warning about hand sanitizer products that contain methanol (wood alcohol), a substance often used to create fuel and antifreeze, has been issued by the U.S. Food and Drug Administration.
Fight Against COVID-19 Threatens Progress Against Other Diseases
MONDAY, July 6, 2020 (HealthDay News) — Decades of progress against HIV, tuberculosis, malaria, and other diseases worldwide are threatened by the diversion of resources on the COVID-19 pandemic, the International AIDS Society says in a report to be published this week.
CNN Article
Health Expenditures Considerable for Asthma, COPD in U.S. Workers
MONDAY, July 6, 2020 (HealthDay News) — The annualized total medical expenditures for asthma and chronic obstructive pulmonary disease (COPD) are $7 billion and $5 billion among U.S. workers, respectively, according to research published in the July 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use
MONDAY, July 6, 2020 (HealthDay News) — The use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers is associated with a lower risk for colorectal cancer that develops within three years after index colonoscopy, according to a study published online July 6 in Hypertension.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 29 to July 3, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
HDHPs Up Disparities in Access to Care Among Cancer Survivors
THURSDAY, July 2, 2020 (HealthDay News) — For cancer survivors, high-deductible health plans (HDHPs) are associated with cost-related barriers to care, and these barriers are greater for black cancer survivors, according to a study published online June 24 in JAMA Network Open.
Treatment Up for U.S. Adults Who Screen Positive for Depression
THURSDAY, July 2, 2020 (HealthDay News) — From 2007 to 2016, there was an increase in the proportion of adults who screened positive for depression receiving any treatment, according to a research letter published online July 1 in JAMA Psychiatry.
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
THURSDAY, July 2, 2020 (HealthDay News) — An estimated 1.5 percent of American adults purchase prescription medication from outside of the United States to save money, according to a study published online June 24 in JAMA Network Open.
Medical Management Alone Better for Brain AV Malformations
THURSDAY, July 2, 2020 (HealthDay News) — Among patients with unruptured brain arteriovenous malformation, medical management alone is superior to its combination with interventional therapy for prevention of death or symptomatic stroke in the long term, according to a study published in the July 1 issue of The Lancet Neurology.
Post-Vaxx Febrile Seizures Not Linked to Child Development Outcomes
WEDNESDAY, July 1, 2020 (HealthDay News) — Young children experiencing an initial vaccine-proximate (VP) febrile seizure (FS) do not have increased risk of developmental or behavioral problems, according to a study published online July 1 in Neurology.
Promising Results for Experimental COVID-19 Vaccine in Early Testing
WEDNESDAY, July 1, 2020 (HealthDay News) — An experimental COVID-19 vaccine yielded promising results in early testing, according to Pfizer and its German partner BioNTech.
AP News Article
U.S. Grab of Only COVID-19 Treatment Outrages Health Experts
WEDNESDAY, July 1, 2020 (HealthDay News) — The United States’ deal with Gilead Sciences to scoop up nearly all of the world’s supply of the only drug licensed to treat COVID-19 has outraged health experts.
AP News Article
2005 to 2016 Saw Increase in Skeletal Muscle Relaxant Use
WEDNESDAY, July 1, 2020 (HealthDay News) — From 2005 to 2016, skeletal muscle relaxant (SMR) use increased in the United States, according to a study published online June 24 in JAMA Network Open.
Copyright © 2020 ScoutNews, LLC. All rights reserved.
